Biotech · Private company
Orasis Pharmaceuticals Ltd.
Track this companyFree. Adds Orasis Pharmaceuticals Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- CSF-1Phase 3 · PresbyopiaClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 3 · PresbyopiaClinicalTrials.gov · fetched Nov 12, 2026
- CSF-1 Component #1Phase 2 · PresbyopiaClinicalTrials.gov · fetched Nov 12, 2026
- CSF-1 Component #2Phase 2 · PresbyopiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- An Evaluation of the Safety of CSF-1 in Presbyopic SubjectsPHASE3 · COMPLETED · started Apr 22, 2022ClinicalTrials.gov NCT05393895 · fetched Nov 12, 2026
- An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)PHASE3 · COMPLETED · started Oct 26, 2020ClinicalTrials.gov NCT04599972 · fetched Nov 12, 2026
- An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1)PHASE3 · COMPLETED · started Oct 18, 2020ClinicalTrials.gov NCT04599933 · fetched Nov 12, 2026
- A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of PresbyopiaPHASE2 · COMPLETED · started Feb 26, 2019ClinicalTrials.gov NCT03885011 · fetched Nov 12, 2026